Aim: The aim of the present study was to clarify differences in node metastasis mode and clinical outcomes based on tumor location in patients with esophageal squamous cell carcinoma (ESCC). Patients and Methods: Participants comprised 228 patients with ESCC who underwent radical esophagectomy without preoperative supplement therapies. Lymph nodes were harvested from three fields: the neck, thorax, and abdomen. Patients were divided into three groups depending on tumor location [upper esophagus (UE), middle esophagus, or lower esophagus (LE)] and analyzed clinicopathologically. Results: The LE group showed significantly more progressive ESCC in terms of tumor invasion (p = 0.025), node metastasis (p = 0.0071), and TNM stage (p = 0.0043). The LE group revealed a tendency to metastasize to extrathoracic (especially abdominal) nodes (p = 0.0008). Recurrent laryngeal node metastasis was increased in the UE group (p = 0.016). However, no prognostic differences were detected between groups according to tumor location. Likewise, subgroup analyses by surgical approach (open thoracotomy vs. thoracoscopy) and cancer stage (stage I/II, III, and IV) did not reveal any significant prognostic impact of tumor location. Conclusion: Lymphatic spread varied by tumor location, but no prognostic impact of tumor location could be detected in patients with ESCC in spite of surgical approach or cancer stage.

1.
Skandalakis JE, Gray SW, Ricketts R: Embryology for Surgeons: the Embryological Basis for the Treatment of Congenital Anomalies, ed 2. Lippincott Williams and Wilkins, 1993, pp 65-112.
2.
Nakano S, Baba M, Shimada M, Shirao K, Noguchi Y, Kusano C, Natsugoe S, Yoshinaka H, Fukumoto T, Aikou T: How the lymph node metastases toward cervico-upper mediastinal region affect the outcome of patients with carcinoma of the thoracic esophagus. Jpn J Clin Oncol 1999;29:248-251.
3.
Li H, Zhang Y, Cai H, Xiang J: Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy. Eur Surg Res 2007;39:1-6.
4.
Li B, Chen H, Xiang J, Zhang Y, Li C, Hu H, Zhang Y: Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg 2012;144:778-785, discussion 785-786.
5.
Kato H, Tachimori Y, Watanabe H, Yamaguchi H, Ishikawa T, Kagami Y: Thoracic esophageal carcinoma above the carina: a more formidable adversary? J Surg Oncol 1997;65:28-33.
6.
Tachibana M, Kinugasa S, Dhar DK, Kotoh T, Shibakita M, Ohno S, Masunaga R, Kubota H, Kohno H, Nagasue N: Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Surg Oncol 1999;72:88-93.
7.
Law S, Kwong DL, Kwok KF, Wong KH, Chu KM, Sham JS, Wong J: Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 2003;238:339-347, discussion 347-348.
8.
Li H, Zhang Q, Xu L, Chen Y, Wei Y, Zhou G: Factors predictive of prognosis after esophagectomy for squamous cell cancer. J Thorac Cardiovasc Surg 2009;137:55-59.
9.
Doki Y, Ishikawa O, Takachi K, Miyashiro I, Sasaki Y, Ohigashi H, Murata K, Yamada T, Noura S, Eguchi H, Kabuto T, Imaoka S: Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg 2005;29:700-707.
10.
Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW: An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 2007;245:717-725.
11.
Yang HX, Hou X, Liu QW, Zhang LJ, Liu JG, Lin P, Fu JH: Tumor location does not impact long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China. Ann Thorac Surg 2012;93:1861-1866.
12.
Sobin LH, Gospodarowicz MK, Wittekind C (eds): UICC TNM Classification of Malignant Tumours, ed 7. Oxford, Wiley-Blackwell, 2009, pp 63-72.
13.
Takeno S, Yamashita SI, Yamamoto S, Takahashi Y, Moroga T, Kawahara K, Shiroshita T, Yamana I, Maki K, Yamashita Y: Number of metastasis-positive lymph node stations is a simple and reliable prognostic factor following surgery in patients with esophageal cancer. Exp Ther Med 2012;4:1087-1091.
14.
Stiles BM, Mirza F, Port JL, Lee PC, Paul S, Christos P, Altorki NK: Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer. Ann Thorac Surg 2010;90:1805-1811, discussion 1811.
15.
Udagawa H, Ueno M, Shinohara H, Haruta S, Kaida S, Nakagawa M, Tsurumaru M: The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol 2012;106:742-747.
16.
Parameswaran R, Veeramootoo D, Krishnadas R, Cooper M, Berrisford R, Wajed S: Comparative experience of open and minimally invasive esophagogastric resection. World J Surg 2009;33:1868-1875.
17.
Berger AC, Bloomenthal A, Weksler B, Evans N, Chojnacki KA, Yeo CJ, Rosato EL: Oncologic efficacy is not compromised, and may be improved with minimally invasive esophagectomy. J Am Coll Surg 2011;212:560-566, discussion 566-568.
18.
Singh RK, Pham TH, Diggs BS, Perkins S, Hunter JG: Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma. Arch Surg 2011;146:711-714.
19.
Kinjo Y, Kurita N, Nakamura F, Okabe H, Tanaka E, Kataoka Y, Itami A, Sakai Y, Fukuhara S: Effectiveness of combined thoracoscopic-laparoscopic esophagectomy: comparison of postoperative complications and midterm oncological outcomes in patients with esophageal cancer. Surg Endosc 2012;26:381-390.
20.
Takeno S, Takahashi Y, Moroga T, Kawahara K, Yamashita Y, Ohtaki M: Retrospective study using the propensity score to clarify the oncological feasibility of thoracoscopic esophagectomy in patients with esophageal cancer. World J Surg 2013;37:1673-1680.
21.
Rice TW, Rusch VW, Ishwaran H, Blackstone EH, Worldwide Esophageal Cancer Collaboration: Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 2010;116:3763-3773.
22.
Rice TW, Blackstone EH, Rusch VW: 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 2010;17:1721-1724.
23.
Rice TW, Blackstone EH, Rusch VW: A cancer staging primer: esophagus and esophagogastric junction. J Thorac Cardiovasc Surg 2010;139:527-529.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.